TY  - JOUR

T1  - Early Cost-Utility Analysis of Ataluren and Eteplirsen in the Treatment of Duchenne Muscular Dystrophy in Egypt

JO  - Value in Health Regional Issues

UR  - http://dx.doi.org/10.1016/j.vhri.2023.08.004

PY  - 2023/10/18

AU  - Shehata Z

AU  - Metry A

AU  - Rabea H

AU  - El Sherif R

AU  - Abdelrahim M

AU  - Dawoud D

ED  - 

DO  - DOI: 10.1016/j.vhri.2023.08.004

PB  - Elsevier BV

VL  - 38

SP  - 109

EP  - 117

Y2  - 2025/04/07

ER  -